KIAA1429/VIRMA通过m6的A-依赖细胞质HAS2稳定促进乳腺癌的进展
Na Li1, Zhouting Zhu1, Yufei Deng1
1Division of Genetics, Department of Pediatrics, Program in Immunology, Bioinformatics and Systems Biology Program, Institute for Genomic Medicine, La Jolla, CA, USA.
在乳腺癌中,m6A编辑器KIAA1429/VIRMA被上调,通过通过IGF2BP3.3稳定HAS2mRNA,促进瘤生长和低生存率. 针对这一轴可能会提供新的乳腺癌疗法.
科学领域:
- * 分子生物学 * 分子生物学
- * 瘤学 瘤学是一门专业.
- * 表观遗传学 是一种表观遗传学.
背景情况:
- *N6-甲基氨酸 (m6A) 是一种关键的mRNA修饰,影响癌症中的基因表达.
- *m6A调控涉及甲基转移酶,脱甲基酶和m6A结合蛋白.
- *m6A通路的失调有助于癌症的发展和进展.
研究的目的:
- * 研究m6A调控蛋白在乳腺癌中的作用.
- * 确定KIAA1429/VIRMA在乳腺癌中的临床意义.
- *阐明KIAA1429/VIRMA影响乳腺癌进展的分子机制.
主要方法:
- *分析乳腺癌组织和细胞系中的KIAA1429/VIRMA表达.
- *由shRNA介导的KIAA1429/VIRMA的敲除.
- * 调查KIAA1429/VIRMA与IGF2BP3和HAS2mRNA的相互作用.
- *KIAA1429/VIRMA,IGF2BP3和HAS2mRNA水平与患者存活时间的相关性分析.
主要成果:
- *KIAA1429/VIRMA表达在乳腺癌中被上调,与生存率差相关.
- *KIAA1429/VIRMA被误局到乳腺癌细胞中的细胞质中.
- * 抑制KIAA1429/VIRMA可以抑制乳腺癌细胞的增殖,迁移和入侵.
- *KIAA1429/VIRMA与IGF2BP3结合,以稳定m6A修饰的HAS2mRNA.
结论:
- *KIAA1429/VIRMA-IGF2BP3-HAS2轴促进乳腺癌的生长和进展.
- *KIAA1429/VIRMA是乳腺癌的潜在治疗点.
- *KIAA1429/VIRMA的上调表明乳腺癌患者的预后不佳.
更多相关视频
09:08Integration of Bioinformatics Approaches and Experimental Validations to Understand the Role of Notch Signaling in Ovarian Cancer
Published on: January 12, 2020
07:13Initiation of Metastatic Breast Carcinoma by Targeting of the Ductal Epithelium with Adenovirus-Cre: A Novel Transgenic Mouse Model of Breast Cancer
Published on: March 26, 2014
相关概念视频
mTOR Signaling and Cancer Progression
The mTOR pathway or the...
Abnormal Proliferation
Destabilization of Microtubules
PI3K/mTOR/AKT Signaling Pathway
Cancer-Critical Genes II: Tumor Suppressor Genes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...
The Nucleolus
